Our Liver Cancer Program offers the full spectrum of therapies for primary liver cancers, also known as hepatocellular carcinoma and choangiocarcinoma.

Liver cancer rates are increasing rapidly. Incidence of both liver cancer and bile duct cancer has more than tripled since 1980. In the United States, about 41,000 new cases are diagnosed each year. Fortunately, treatment advances and improved surgical techniques have kept mortality from the disease from increasing. Our team is dedicated to diagnosing liver cancer early, when treatment is optimal, and to discovering new, more effective treatment options for our patients.